- Article
- Source: Campus Sanofi
- Jun 23, 2026
Pompe Care Podcast Series 3
Today we speak with Dr. Nadia Alhashmi, Senior Consultant in Chemical & Bio-Chemical Genetics at the National Genetics Royal Hospital in Oman, and Dr. Khalid Althihli, Senior Consultant in Chemical & Bio-Chemical Genetics at Sultan Qaboos University Hospital in Oman. With deep expertise in rare metabolic and genetic disorders, both specialists bring frontline clinical perspectives on Pompe disease — covering the typical patient journey, diagnostic challenges, and new diagnostic technologies, while sharing their compassionate approach to supporting patients and families and addressing the social stigma surrounding rare diseases.
Episode 1:
What factors influence your decision to switch a patient from alglucosidase alfa to avalglucosidase alfa?
Episode 2:
How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?
Episode 3:
Have you observed any significant differences in treatment outcomes between these two therapies in your local practice?
Episode 4:
What challenges do clinicians face in monitoring in disease progrission and response to therapy?
MAT-KW-2600384-V1-Jul-26